AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021
Mar 3, 2021
31049_dirs_2021-03-02_8eb35836-a5eb-46f3-a0f6-5959cea24e53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-02-26
Reporting Person: Wright Joseph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-26 | Common Stock, No Par Value | A | 3315 | — | Acquired | 13315 | Direct |
| 2021-02-26 | Common Stock, No Par Value | F | 972 | $55.72 | Disposed | 12343 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $12.06 | 2021-10-04 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $17.27 | 2022-02-13 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (20000) | 20000 | Direct |
| Non-qualified stock options (right to buy) | $28.20 | 2024-04-14 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $44.80 | 2025-03-02 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $55.73 | 2026-03-01 | Common Stock (30000) | 30000 | Direct |
| Non-qualified stock options (right to buy) | $37.71 | 2027-02-26 | Common Stock (16722) | 16722 | Direct |
Footnotes
F1: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020.
F2: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
F3: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
F4: Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
F5: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F6: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F7: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F8: Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.